| Ory Holtzman, MD | |
|
209 Martin Luther King Jr Way, Tacoma, WA 98405-4265 | |
| (253) 596-3300 | |
| Not Available |
| Full Name | Ory Holtzman |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 15 Years |
| Location | 209 Martin Luther King Jr Way, Tacoma, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295979169 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | D0075550 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
News Archive
BioInvent International AB has announced that it has entered into a licence and discovery agreement with DAIICHI SANKYO COMPANY, LIMITED for the development of therapeutic antibodies against multiple targets. Under the terms of the collaboration, Daiichi Sankyo will be granted broad access to BioInvent's discovery and development technology platform and in house antibody expertise. As part of the agreement, BioInvent has secured certain co-promotion rights in Scandinavia and the Baltic countries.
ChromaDex Corporation, a leader in phytochemical reference standards and contract research, today announced financial results for the Fiscal Year ending January 2, 2010. On a reported basis calculated in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ChromaDex announced a net loss attributable to common stockholders of $0.03 per share for the one year period ended January 2, 2010. As of January 2, 2010, cash, cash equivalents, and marketable securities totaled $471,378.
CQ Politics reports that Rep. Mary Jo Kilroy, D-Ohio, is one of several women lawmakers who is using her own history with multiple sclerosis to lobby for changes in the health care system: "As the health care debate rages on, [Kilroy] has decided to use her personal story to help fellow lawmakers understand how important it is to make health care available for all Americans. In a 'Dear Colleague' letter she sent last week, Kilroy told them about her own diagnosis."
The use of citric acid in e-liquids needs to be investigated to further understand its potential to form potentially harmful anhydrides in the vapour.
› Verified 5 days ago
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
BioInvent International AB has announced that it has entered into a licence and discovery agreement with DAIICHI SANKYO COMPANY, LIMITED for the development of therapeutic antibodies against multiple targets. Under the terms of the collaboration, Daiichi Sankyo will be granted broad access to BioInvent's discovery and development technology platform and in house antibody expertise. As part of the agreement, BioInvent has secured certain co-promotion rights in Scandinavia and the Baltic countries.
ChromaDex Corporation, a leader in phytochemical reference standards and contract research, today announced financial results for the Fiscal Year ending January 2, 2010. On a reported basis calculated in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ChromaDex announced a net loss attributable to common stockholders of $0.03 per share for the one year period ended January 2, 2010. As of January 2, 2010, cash, cash equivalents, and marketable securities totaled $471,378.
CQ Politics reports that Rep. Mary Jo Kilroy, D-Ohio, is one of several women lawmakers who is using her own history with multiple sclerosis to lobby for changes in the health care system: "As the health care debate rages on, [Kilroy] has decided to use her personal story to help fellow lawmakers understand how important it is to make health care available for all Americans. In a 'Dear Colleague' letter she sent last week, Kilroy told them about her own diagnosis."
The use of citric acid in e-liquids needs to be investigated to further understand its potential to form potentially harmful anhydrides in the vapour.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ory Holtzman, MD 209 Martin Luther King Jr Way, Tacoma, WA 98405-4265 Ph: (253) 596-3300 | Ory Holtzman, MD 209 Martin Luther King Jr Way, Tacoma, WA 98405-4265 Ph: (253) 596-3300 |
News Archive
BioInvent International AB has announced that it has entered into a licence and discovery agreement with DAIICHI SANKYO COMPANY, LIMITED for the development of therapeutic antibodies against multiple targets. Under the terms of the collaboration, Daiichi Sankyo will be granted broad access to BioInvent's discovery and development technology platform and in house antibody expertise. As part of the agreement, BioInvent has secured certain co-promotion rights in Scandinavia and the Baltic countries.
ChromaDex Corporation, a leader in phytochemical reference standards and contract research, today announced financial results for the Fiscal Year ending January 2, 2010. On a reported basis calculated in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ChromaDex announced a net loss attributable to common stockholders of $0.03 per share for the one year period ended January 2, 2010. As of January 2, 2010, cash, cash equivalents, and marketable securities totaled $471,378.
CQ Politics reports that Rep. Mary Jo Kilroy, D-Ohio, is one of several women lawmakers who is using her own history with multiple sclerosis to lobby for changes in the health care system: "As the health care debate rages on, [Kilroy] has decided to use her personal story to help fellow lawmakers understand how important it is to make health care available for all Americans. In a 'Dear Colleague' letter she sent last week, Kilroy told them about her own diagnosis."
The use of citric acid in e-liquids needs to be investigated to further understand its potential to form potentially harmful anhydrides in the vapour.
› Verified 5 days ago
Dr. Melodie M Icasiano, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Madigan Army Medical Center, Bldg 9040 Fitzsimmons Dr., Tacoma, WA 98431 Phone: 253-968-1740 | |
Dr. Angela Lorraine Gray, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1608 S J St Fl 1, Tacoma, WA 98405 Phone: 253-274-7501 Fax: 206-246-0468 | |
James Lin, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 521 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-4747 | |
Amanda Carpenter Cousins, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 9040 Jackson Ave Madigan Army Medical Center, Tacoma, WA 98431 Phone: 301-295-4000 | |
Ladonna Rae Jones, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 314 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-9860 | |
Dr. Karen M Nelson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 314 Martin Luther King Jr Way, Suite 400, Tacoma, WA 98405 Phone: 253-627-0666 | |
Rachel Y Kim, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3300 Fax: 253-596-3301 |